Development and Validation of a Short Version of the Kansas City Cardiomyopathy Questionnaire.

Authors:
Spertus JA; Jones PG.

Journal:
Circ Cardiovasc Qual Outcomes

Publication Year: 2015

DOI:
10.1161/CIRCOUTCOMES.115.001958

PMCID:
PMC4885562

PMID:
26307129

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Circ Cardiovasc Qual Outcomes

Abbreviation: Circ Cardiovasc Qual Outcomes

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Vascular Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Trends in Patient Access to and Utilization of Prescribed PCSK9 Inhibitors in a Large US Claims Dat…
MacDougall DE; Baum SJ; Ahmed CD and 2 more (2024) - Transparency Score: 3/6
Cost-Effectiveness of AF Screening With 2-Week Patch Monitors: The mSToPS Study.
Reynolds MR; Stein AB; Sun X and 3 more (2023) - Transparency Score: 4/6
Discrimination Experiences and All-Cause and Cardiovascular Mortality: Multi-Ethnic Study of Athero…
Lawrence WR; Jones GS; Johnson JA and 5 more (2023) - Transparency Score: 3/6
Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Cr…
Lu Y; Liu Y; Jastreboff AM and 5 more (2023) - Transparency Score: 3/6
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction: Cost-Effectiveness Analys…
Chivardi C; Morgan H; Sculpher MJ and 10 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosures Dr Spertus discloses that he owns the copyright to the KCCQ, SAQ, and PAQ; has grant support from Lilly, Abbott Vascular, and Genentech; provides scientific consulting services to Amgen, Novartis, Janssen, and Regeneron; and has an equity interest in Health Outcomes Science."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025